350 related articles for article (PubMed ID: 19272804)
1. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
[TBL] [Abstract][Full Text] [Related]
2. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
Scheper MA; Nikitakis NG; Sauk JJ
Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
[TBL] [Abstract][Full Text] [Related]
3. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma.
Scheper MA; Nikitakis NG; Chaisuparat R; Montaner S; Sauk JJ
Neoplasia; 2007 Mar; 9(3):192-9. PubMed ID: 17401459
[TBL] [Abstract][Full Text] [Related]
4. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
Scheper MA; Sauk JJ; Nikitakis NG
Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
[TBL] [Abstract][Full Text] [Related]
5. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
Nikitakis NG; Hamburger AW; Sauk JJ
Cancer Res; 2002 Feb; 62(4):1004-7. PubMed ID: 11861373
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
Nikitakis NG; Hebert C; Lopes MA; Reynolds MA; Sauk JJ
Int J Cancer; 2002 Apr; 98(6):817-23. PubMed ID: 11948457
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors.
Nikitakis NG; Scheper MA; Papanikolaou VS; Sklavounou A; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):837-43. PubMed ID: 19272817
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
9. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
10. [Apoptosis resistance induced by leptin and its mechanism in breast cancer cells].
Zhao TS; Jiang HP; Wang XC; Ren H; Hao JH
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):651-4. PubMed ID: 20021858
[TBL] [Abstract][Full Text] [Related]
11. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
[TBL] [Abstract][Full Text] [Related]
12. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
Wu MH; Chen XY; Cai KR
Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
[TBL] [Abstract][Full Text] [Related]
13. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines.
Naramoto H; Uematsu T; Uchihashi T; Doto R; Matsuura T; Usui Y; Uematsu S; Li X; Takahashi M; Yamaoka M; Furusawa K
Int J Oncol; 2007 Feb; 30(2):393-401. PubMed ID: 17203221
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
[TBL] [Abstract][Full Text] [Related]
16. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
[TBL] [Abstract][Full Text] [Related]
17. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
[TBL] [Abstract][Full Text] [Related]
18. Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis.
Greening DW; Ji H; Kapp EA; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2293-307. PubMed ID: 23899461
[TBL] [Abstract][Full Text] [Related]
19. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression.
Glienke W; Maute L; Wicht J; Bergmann L
Cancer Invest; 2010 Feb; 28(2):166-71. PubMed ID: 20121547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
